Mitral valve regurgitation

Current Problems in Cardiology

Volumn 23, Issue 4, 1998, Pages 197-241

  Carabello, Blase A ^{a,b,c,d,e,f,g}  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^d AMERICAN HEART ASSOCIATION   (United States)

^e AMERICAN COLLEGE OF CARDIOLOGY   (United States)

^f Association of University Cardiologists   (United States)

^g American Society for Clinical Investigation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENFLURAMINE; NITROPRUSSIDE SODIUM; PHENTERMINE; QUINAPRIL; SEROTONIN AGONIST; VASODILATOR AGENT;

ACUTE DISEASE; ANAMNESIS; BETA ADRENERGIC STIMULATION; CHRONIC DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DOPPLER FLOWMETRY; DRUG EFFICACY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXERCISE; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MITRAL VALVE PROLAPSE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; NONHUMAN; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; REVIEW; SURGICAL RISK; THORAX RADIOGRAPHY; TREATMENT PLANNING; VALVULOPLASTY; ANIMAL; DOPPLER ECHOCARDIOGRAPHY; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART VALVE REPLACEMENT; MITRAL VALVE; PHYSIOLOGY; SYSTOLE;

ANIMALS; CHRONIC DISEASE; ECHOCARDIOGRAPHY, DOPPLER; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; MYOCARDIAL CONTRACTION; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0032041027     PISSN: 01462806     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0146-2806(98)80005-4     Document Type: Article

References (31)

1. Waller BF, Howard J, Fess S. Pathology of mitral valve stenosis and pure mitral regurgitation: Part II. Clin Cardiol 1994;17(7):395-402.
2. Levine RA, Stathogiannis E, Newell JB, et al. Reconsideration of echocardiographic standards for mitral valve prolapse: lack of association between leaflet displacement isolated to the apical four chamber view and independent echocardiographic evidence of abnormality. J Am Coll Cardiol 1988;11(5):1010-9.
3. Düren DR, Becker AE, Dunning AJ. Long-term follow-up of idiopathic mitral valve prolapse in 300 patients: aprospective study. J Am Coll Cardiol 1988;11(1):42-7.
4. Wilcken DE, Hickey AJ. Lifetime risk for patients with mitral valve prolapse of developing severe valve regurgitation requiring surgery. Circulation 1988;78(1):10-4.
5. Mills P, Rose J, Hollingsworth J, et al. Long-term prognosis of mitral-valve prolapse. N Engl J Med 1977;297(1):13-8.
6. Kolibash AJ Jr, Kilman JW, Bush CA, et al. Evidence for progression from mild to severe mitral regurgitation in mitral valve prolapse. Am J Cardiol 1986;58(9):762-7.
7. Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997;337(9):581-8.
8. Carabello BA. Mitral regurgitation, Part 1: basic pathophysiologic principles. Mod Concepts Cardiovasc Dis 1988;57(10):53-8.
9. Ross J Jr, Sonnenblick EH, Taylor RR, et al. Diastolic geometry and sarcomere lengths in the chronically dilated canine left ventricle. Circ Res 1971;28(1):49-61.
10. Urschel CW, Covell JWS, Sonnenblick EH, et al. Myocardial mechanics in aortic and mitral valvular regurgitation: the concept of instantaneous impedance as a determinant of the performance of the intact heart. J Clin Invest 1968;47(4):867-83.
11. Corin WJ, Monrad ES, Murakami T, et al. The relationship of afterload to ejection performance in chronic mitral regurgitation. Circulation 1987;76(1):59-67.
12. Mulieri LA, Leavitt BJ, Martin BJ, et al. Myocardial force-frequency defect in mitral regurgitation heart failure is reversed by forskolin. Circulation 1993;88(6):2700-4.
13. Mulieri LA, Leavitt BJ, Ittleman FP, et al. Forskolin reverses the force-frequency defect in left ventricular subepicardium (EPI) but not in papillary myocardium (PAP) in human mitral regurgitation heart failure. Circulation 1993;88 Suppl 1:406.
14. Kleaveland JP, Kussmaul WG, Vinciguerra T, et al. Volume overload hypertrophy in a closed-chest model of mitral regurgitation. Am J Physiol 1988;254(6, Pt 2):H1034-41.
15. Carabello BA, Nakano K, Ishihara K, et al. Coronary blood flow in dogs with contractile dysfunction due to experimental volume overload. Circulation 1991;83(3):1063-75.
16. Urabe Y, Mann DL, Kent RL, et al. Cellular and ventricular contractile dysfunction in experimental canine mitral regurgitation. Circ Res 1992;70(1):131-47.
17. Nakano K, Swindle MM, Spinale F, et al. Depressed contractile function due to canine mitral regurgitation improves after correction of the volume overload. J Clin Invest 1991;87(6):2077-86.
18. Rozich JD, Carabello BA, Usher BW, et al. Mitral valve replacement with and without chordal preservation in patients with chronic mitral regurgitation: mechanism for differences in postoperative ejection performance. Circulation 1992;86(6):1718-27.
19. Ishihara K, Zile MR, Kanazawa S, et al. Left ventricular mechanics and myocyte function after correction of experimental chronic mitral regurgitation by combined mitral valve replacement and preservation of the native mitral valve apparatus. Circulation 1992;86 Suppl 11:16-25.
20. Spinale FG, Ishihara K, Zile M, et al. Structural basis for changes in left ventricular function and geometry because of chronic mitral regurgitation and after correction of volume overload. J Thorac Cardiovasc Surg 1993;106(6):1147-57.
21. Imamura T, McDermott PJ, Kent RL, et al. Acute changes in myosin heavy chain synthesis rate in pressure versus volume overload. Circ Res 1994;75(3):418-25.
22. Chidsey CA, Harrison DC, Brauwald E. Augmentation of the plasma norepinephrine response to exercise in patients with congestive heart failure. N Engl J Med 1962;267:650-4.
23. Rona G, Chappel CI, Balazs T, et al. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Arch Pathol 1959;67:443-55.
24. Tsutsui H, Spinale FG, Nagatsu M, et al. Effects of chronic β-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation. J Clin Invest 1994;93(6):2639-48.
25. Matsuo T, Carabello BA, Koide M, et al. Mechanisms of increased heavy chain synthesis rate in volume overload hypertrophy [abstract]. Circulation 1995;92(8) Suppl 1:587.
26. Zile MR, Tomita M, Nakano K, et al. Effects of left ventricular volume overload produced by mitral regurgitation on diastolic function. Am J Physiol 1991;261(5 Pt 2):H1471-80.
27. Zile MR, Tomita M, Ishihara K, et al. Changes in diastolic function during development and correction of chronic LV volume overload produced by mitral regurgitation. Circulation 1993;87(4):1378-88.
28. Corin WJ, Murakami T, Monrad ES, et al. Left ventricular passive diastolic properties in chronic mitral regurgitation. Circulation 1991;83(3):797-807.
29. Desjardins VA, Enriquez-Sarano M, Tajik J, et al. Intensity of murmurs correlates with severity of valvular regurgitation. Am J Med 1996;100(2):149-56.
30. Karliner JS, O'Rourke RA, Kearney DJ, et al. Haemodynamic explanation of why the murmur of mitral regurgitation is independent of cycle length. Br Heart J 1973;35(4):397-401.
31. Wisenbaugh T, Spann JF, Carabello BA. Differences in myocardial performance and load between patients with similar amounts of chronic aortic versus chronic mitral regurgitation. J Am Coll Cardiol 1984;3(4):916-23.